Jenifer Hendel

Title: **Innovator Spotlight: Jenifer Hendel**

Introduction

Jenifer Hendel, a distinguished inventor based in Alymer, CA, has made notable contributions to the field of glycomimetics. With a focus on inhibiting pathogen-host interactions, her innovative work is paving the way for advancements in medical and pharmaceutical research.

Latest Patents

Jenifer Hendel holds a patent for "Glycomimetics to inhibit pathogen-host interactions". This invention centers around novel glycomimetic compounds specifically designed to prevent the binding of various pathogens to cell surface sialylated galactose. The patent elucidates methods involving sialic acid glycosides and C-glycosides that form specialized cyclic structures with adjacent monosaccharide residues, showcasing Hendel's groundbreaking approach to tackling infectious diseases.

Career Highlights

Throughout her career, Hendel has engaged with prominent research institutions, notably the University of Georgia Research Foundation, Inc. and the National University of Ireland, Galway. Her work has significantly contributed to enhancing our understanding of pathogen interactions and the development of potential therapeutic interventions.

Collaborations

Jenifer has collaborated with esteemed colleagues, including Robert J Woods and Paul V Murphy. These partnerships have facilitated the exploration of innovative solutions in her research area, further solidifying her role as a key player in scientific advancements.

Conclusion

In conclusion, Jenifer Hendel exemplifies the spirit of innovation and dedication to improving health outcomes through her pioneering inventions. Her contributions in glycomimetics highlight the importance of research in combating pathogen-related challenges, marking her as a prominent inventor within the scientific community.